Barinthus Biotherapeutics PLC. (BRNS) — 10-Q Filings
All 10-Q filings from Barinthus Biotherapeutics PLC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Barinthus Bio's Losses Widen Amidst Zero Revenue, Announces Merger
— Nov 7, 2025 Risk: high
Barinthus Biotherapeutics plc reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $55.355 million, compared to $4 -
Barinthus Biotherapeutics Widens Q2 Loss Amid R&D Spend
— Aug 7, 2025 Risk: high
Barinthus Biotherapeutics plc. reported no revenue for the six months ended June 30, 2025, consistent with its clinical-stage status. The company recorded a net -
Barinthus Biotherapeutics plc Files Q1 2025 10-Q
— May 7, 2025 Risk: medium
Barinthus Biotherapeutics plc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Vaccitech plc, is focused on pharmaceutical p -
Barinthus Biotherapeutics plc. Files Q3 2024 10-Q
— Nov 6, 2024 Risk: medium
Barinthus Biotherapeutics plc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Vaccitech plc, reported financial results -
Barinthus Biotherapeutics plc. Files Q2 2024 10-Q
— Aug 8, 2024 Risk: medium
Barinthus Biotherapeutics plc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Vaccitech plc, reported financial results and
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX